Rubicon Technology, Inc.  

(Public, NASDAQ:RBCN)   Watch this stock  
Find more results for RBCN
8.24
+0.16 (1.98%)
Real-time:   10:46AM EDT
NASDAQ real-time data - Disclaimer
Currency in USD
Range 8.04 - 8.28
52 week 6.93 - 14.67
Open 8.15
Vol / Avg. 100,660.00/471,768.00
Mkt cap 215.53M
P/E     -
Div/yield     -
EPS -1.62
Shares 26.16M
Beta 0.84
Inst. own 106%
Aug 7, 2014
Q2 2014 Rubicon Technology Inc Earnings Call - 5:00PM EDT - Add to calendar
Aug 7, 2014
Q2 2014 Rubicon Technology Inc Earnings Release - 4:00PM EDT - Add to calendar
Jun 25, 2014
Rubicon Technology Inc Annual Shareholder Meeting
May 1, 2014
Q1 2014 Rubicon Technology Inc Earnings Conference Call
May 1, 2014
Q1 2014 Rubicon Technology Inc Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '14) 2013
Net profit margin -76.35% -73.11%
Operating margin -76.57% -84.03%
EBITD margin - -52.11%
Return on average assets -20.25% -13.47%
Return on average equity -21.01% -14.41%
Employees 292 -
CDP Score - -

Address

9931 FRANKLIN AVENUE
FRANKLIN PARK, IL 60131
United States - Map
+1-847-2957000 (Phone)
+1-847-2957555 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Rubicon Technology, Inc. manufactures synthetic electronic materials for opto-electronic, semiconductor fabrication, telecommunications, and optical & laser applications. The Company employs the Kyropoulos method to grow high-density single crystal sapphire and other advanced technology materials.

Officers and directors

Don N. Aquilano Independent Chairman of the Board
Age: 46
Bio & Compensation  - Reuters
Raja M. Parvez President, Chief Executive Officer, Director
Age: 55
Bio & Compensation  - Reuters
William F. Weissman Chief Financial Officer, Treasurer, Secretary
Age: 54
Bio & Compensation  - Reuters
Donald R. Caldwell CPA Independent Director
Age: 66
Bio & Compensation  - Reuters
Michael E. Mikolajczyk Independent Director
Age: 61
Bio & Compensation  - Reuters
Raymond J. Spencer Independent Director
Bio & Compensation  - Reuters